rs1056471

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000183.3(HADHB):​c.*136G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.857 in 763,492 control chromosomes in the GnomAD database, including 293,249 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.87 ( 59285 hom., cov: 33)
Exomes 𝑓: 0.85 ( 233964 hom. )

Consequence

HADHB
NM_000183.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.868

Publications

14 publications found
Variant links:
Genes affected
HADHB (HGNC:4803): (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta) This gene encodes the beta subunit of the mitochondrial trifunctional protein, which catalyzes the last three steps of mitochondrial beta-oxidation of long chain fatty acids. The mitochondrial membrane-bound heterocomplex is composed of four alpha and four beta subunits, with the beta subunit catalyzing the 3-ketoacyl-CoA thiolase activity. The encoded protein can also bind RNA and decreases the stability of some mRNAs. The genes of the alpha and beta subunits of the mitochondrial trifunctional protein are located adjacent to each other in the human genome in a head-to-head orientation. Mutations in this gene result in trifunctional protein deficiency. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2013]
HADHB Gene-Disease associations (from GenCC):
  • mitochondrial trifunctional protein deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 2-26290089-G-C is Benign according to our data. Variant chr2-26290089-G-C is described in ClinVar as Benign. ClinVar VariationId is 335410.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.927 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HADHBNM_000183.3 linkc.*136G>C 3_prime_UTR_variant Exon 16 of 16 ENST00000317799.10 NP_000174.1 P55084-1
HADHBNM_001281512.2 linkc.*136G>C 3_prime_UTR_variant Exon 15 of 15 NP_001268441.1 P55084F5GZQ3
HADHBNM_001281513.2 linkc.*136G>C 3_prime_UTR_variant Exon 17 of 17 NP_001268442.1 P55084-2
HADHBXM_011532803.2 linkc.*136G>C 3_prime_UTR_variant Exon 16 of 16 XP_011531105.1 P55084-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HADHBENST00000317799.10 linkc.*136G>C 3_prime_UTR_variant Exon 16 of 16 1 NM_000183.3 ENSP00000325136.5 P55084-1

Frequencies

GnomAD3 genomes
AF:
0.870
AC:
132313
AN:
152162
Hom.:
59230
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.883
Gnomad AMI
AF:
0.913
Gnomad AMR
AF:
0.739
Gnomad ASJ
AF:
0.903
Gnomad EAS
AF:
0.184
Gnomad SAS
AF:
0.817
Gnomad FIN
AF:
0.938
Gnomad MID
AF:
0.968
Gnomad NFE
AF:
0.933
Gnomad OTH
AF:
0.862
GnomAD4 exome
AF:
0.853
AC:
521537
AN:
611212
Hom.:
233964
Cov.:
6
AF XY:
0.859
AC XY:
286689
AN XY:
333710
show subpopulations
African (AFR)
AF:
0.882
AC:
15227
AN:
17266
American (AMR)
AF:
0.635
AC:
26754
AN:
42114
Ashkenazi Jewish (ASJ)
AF:
0.905
AC:
18619
AN:
20566
East Asian (EAS)
AF:
0.162
AC:
5719
AN:
35300
South Asian (SAS)
AF:
0.848
AC:
57743
AN:
68110
European-Finnish (FIN)
AF:
0.941
AC:
37788
AN:
40146
Middle Eastern (MID)
AF:
0.932
AC:
3225
AN:
3462
European-Non Finnish (NFE)
AF:
0.933
AC:
328296
AN:
351750
Other (OTH)
AF:
0.867
AC:
28166
AN:
32498
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
2877
5755
8632
11510
14387
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1376
2752
4128
5504
6880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.870
AC:
132427
AN:
152280
Hom.:
59285
Cov.:
33
AF XY:
0.862
AC XY:
64218
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.883
AC:
36698
AN:
41558
American (AMR)
AF:
0.739
AC:
11294
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.903
AC:
3135
AN:
3470
East Asian (EAS)
AF:
0.185
AC:
955
AN:
5168
South Asian (SAS)
AF:
0.817
AC:
3947
AN:
4830
European-Finnish (FIN)
AF:
0.938
AC:
9959
AN:
10616
Middle Eastern (MID)
AF:
0.969
AC:
285
AN:
294
European-Non Finnish (NFE)
AF:
0.933
AC:
63503
AN:
68032
Other (OTH)
AF:
0.861
AC:
1818
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
746
1493
2239
2986
3732
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
874
1748
2622
3496
4370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.906
Hom.:
7841
Bravo
AF:
0.850
Asia WGS
AF:
0.585
AC:
2038
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mitochondrial trifunctional protein deficiency Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
3.8
DANN
Benign
0.82
PhyloP100
-0.87
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1056471; hg19: chr2-26512957; COSMIC: COSV58546186; API